BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
247 hedge funds and large institutions have $8B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2021 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 79 increasing their positions, 86 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 14 → 14 (0)
8% less repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 86
Holders
247
Holding in Top 10
14
Calls
$96.7M
Puts
$76.2M
Top Buyers
| 1 | +$72M | |
| 2 | +$58.9M | |
| 3 | +$48.1M | |
| 4 |
Holocene Advisors
New York
|
+$39.8M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$37.2M |
Top Sellers
| 1 | -$138M | |
| 2 | -$92.5M | |
| 3 | -$45.9M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$45M |
| 5 |
Goldman Sachs
New York
|
-$42.2M |